发明名称 |
NOVEL USE OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYL-BENZOFURAN-5-YL)-PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS |
摘要 |
The invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran- 5-yl)-piperazine or a physiologically acceptable salt thereof in the treatment of a sub-type anxiety disorder selected from panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorder, social phobia, posttraumatic stress disorder, acute stress indication or generalized-anxiety disorder, in the treatment of dementia, in the treatment of a substance-related disorder, in the treatment of a sexual dysfunction, in the treatment of an eating disorder, anorexia or obesity, or the treatment of fibromyalgia.
|
申请公布号 |
CA2615271(C) |
申请公布日期 |
2011.02.15 |
申请号 |
CA20002615271 |
申请日期 |
2000.05.16 |
申请人 |
MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG |
发明人 |
BARTOSZYK, GERD;SEYFRIED, CHRISTOPH;VAN AMSTERDAM, CHRISTOPH;BOETTCHER, HENNING;SEDMAN, EWEN |
分类号 |
A61K31/496;C07D405/12;A61K31/00;A61K31/495;A61P1/14;A61P3/04;A61P3/06;A61P15/00;A61P15/10;A61P21/00;A61P25/00;A61P25/22;A61P25/28;A61P25/30;A61P29/00 |
主分类号 |
A61K31/496 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|